Olson, MD, discussed findings from a phase 2 study investigating the addition of immunotherapy to chemotherapy for the ...
Taiga Nishihori, MD, senior member in the Blood & Marrow Transplant and Cellular Immunotherapy Department at Moffitt Cancer ...
During a Case-Based Roundtable® event, Daniel George, MD, discussed the results of the CheckMate 9ER trial across favorable, ...
Adam C. Berger, MD, FACS, highlights the challenges and advancements in diagnosing and treating sarcoma, a rare and diverse ...
Small cell lung cancer poses a significant challenge across the world, particularly in low-middle-income countries where it ...
Corey Cutler, MD, MPH, and Hannah Choe, MD, provide future perspectives on the development of axatilimab for patients with ...
Alexandra Gomez Arteaga, MD, discusses the rationale behind a retrospective study comparing Orca-T with posttransplant ...
Francis P. Worden, MD, discusses future plans to investigate combination therapies and other novel treatments in the thyroid ...
Denise Yardley, MD, discusses the takeaways and next steps of an analysis of the NATALEE trial investigating ribociclib in ...
A dendritic cell vaccine called DOC1021 shows early promise in treating pancreatic cancer and has received a fast track ...
In this episode of Targeted Talks, Omid Hamid, MD, discusses data supporting the use of lifileucel for the treatment of ...
The FDA has granted a rare pediatric disease designation to SLS009 for treating pediatric acute myeloid leukemia.